HK1039636A1 - Myelin basic protein peptides and uses thereof - Google Patents

Myelin basic protein peptides and uses thereof

Info

Publication number
HK1039636A1
HK1039636A1 HK02101092.3A HK02101092A HK1039636A1 HK 1039636 A1 HK1039636 A1 HK 1039636A1 HK 02101092 A HK02101092 A HK 02101092A HK 1039636 A1 HK1039636 A1 HK 1039636A1
Authority
HK
Hong Kong
Prior art keywords
basic protein
myelin basic
protein peptides
peptides
myelin
Prior art date
Application number
HK02101092.3A
Other languages
Chinese (zh)
Inventor
S‧阿裏米利
S‧德斯潘德
Original Assignee
科裏克薩公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 科裏克薩公司 filed Critical 科裏克薩公司
Publication of HK1039636A1 publication Critical patent/HK1039636A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK02101092.3A 1998-05-05 2002-02-15 Myelin basic protein peptides and uses thereof HK1039636A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7310998A 1998-05-05 1998-05-05
PCT/US1999/009930 WO1999057241A2 (en) 1998-05-05 1999-05-05 Myelin basic protein peptides and uses thereof

Publications (1)

Publication Number Publication Date
HK1039636A1 true HK1039636A1 (en) 2002-05-03

Family

ID=22111789

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02101092.3A HK1039636A1 (en) 1998-05-05 2002-02-15 Myelin basic protein peptides and uses thereof

Country Status (10)

Country Link
EP (1) EP1080185A4 (en)
JP (1) JP2002513558A (en)
CN (1) CN1308671A (en)
AU (1) AU3789099A (en)
CA (1) CA2330826A1 (en)
HK (1) HK1039636A1 (en)
NO (1) NO20005547L (en)
NZ (1) NZ507901A (en)
WO (1) WO1999057241A2 (en)
ZA (1) ZA200006268B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487480B1 (en) * 2001-05-01 2015-10-07 The Regents of The University of California Fusion molecules for treatment of immune diseases
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
ITFI20010114A1 (en) 2001-06-22 2002-12-22 Univ Firenze GLYCOPEPTIDES, THEIR PREPARATION AND THEIR USE IN THE DIAGNOSIS OR THERAPEUTIC TREATMENT OF MULTIPLE SCLEROSIS
EP2227486B1 (en) * 2007-11-20 2017-03-08 Vianex S.A. Peptide analogues and conjugates thereof
US20180064792A1 (en) * 2015-03-30 2018-03-08 Osaka University Immunizing peptide, method for producing immunizing peptide, pharmaceutical composition for immune disease containing same, and method for treating immune disease
US20220313780A1 (en) * 2019-06-18 2022-10-06 The Scripps Research Institute Methods and compositions for treating inflammatory conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5734023A (en) * 1991-11-19 1998-03-31 Anergen Inc. MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses
IL115766A0 (en) * 1994-10-25 1996-01-19 Immulogic Pharma Corp Composition and treatment for multiple sclerosis
AU6331696A (en) * 1995-06-07 1996-12-30 Anergen, Inc. Fused soluble mhc heterodimer:peptide complexes and their uses

Also Published As

Publication number Publication date
JP2002513558A (en) 2002-05-14
WO1999057241A2 (en) 1999-11-11
WO1999057241A3 (en) 2000-01-13
NO20005547D0 (en) 2000-11-03
AU3789099A (en) 1999-11-23
ZA200006268B (en) 2001-08-22
EP1080185A4 (en) 2005-01-26
CN1308671A (en) 2001-08-15
NO20005547L (en) 2001-01-02
NZ507901A (en) 2003-06-30
WO1999057241A9 (en) 2000-02-17
EP1080185A2 (en) 2001-03-07
CA2330826A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
PL346346A1 (en) Cyclic prosaposin-derived peptides and uses thereof
PL344341A1 (en) Peptides
GB9806806D0 (en) Peptides and uses thereof
EP1056465A4 (en) Antimicrobial peptides and derived metapeptides
AU5340399A (en) Proteases and associated proteins
GB9719879D0 (en) Protein
GB9703681D0 (en) Protein complemention
AP2001002189A0 (en) Genes and proteins and their uses
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
EP1140976A4 (en) Secreted proteins and uses thereof
EP1018551A4 (en) Megsin protein
ZA985999B (en) Protein kinases and uses thereof
GB9918155D0 (en) Proteins and peptides
HK1039636A1 (en) Myelin basic protein peptides and uses thereof
GB9714276D0 (en) Peptides and related compounds
IL137493A0 (en) Svph3-13 and spvh3-17 dna and polypeptides
GB9720784D0 (en) Protein
EP0996457A4 (en) Fsh-releasing peptides
GB9824357D0 (en) Protein and DNA coding therefor
EP1142999A4 (en) Novel protein and dna thereof
EP1111047A4 (en) Novel protein and dna thereof
EP1132472A4 (en) Novel protein and utilization thereof
EP1141269A4 (en) Secreted proteins and uses thereof
EP1122312A4 (en) Novel protein war-1 and gene thereof